Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department
Phase 2
- Conditions
- High Risk for Serious InfluenzaHigh Risk for Pneumonia
- Locations
- ๐บ๐ธ
Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States
๐บ๐ธBaton Rouge General Medical Center, Baton Rouge, Louisiana, United States
Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy
Phase 4
Completed
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2009-02-04
- Target Recruit Count
- 400
- Registration Number
- NCT00351871
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
Phase 1
- Conditions
- Malignant Mesothelioma
- Locations
- ๐บ๐ธ
Louisiana State University School of Medicine, New Orleans, Louisiana, United States
Evaluation of Implants Placed Immediately or Delayed Into Extraction Sites
Phase 3
- Conditions
- Dental Caries
- First Posted Date
- 2003-08-20
- Last Posted Date
- 2010-11-09
- Target Recruit Count
- 90
- Registration Number
- NCT00067392
- Locations
- ๐บ๐ธ
LSU School of Dentistry, New Orleans, Louisiana, United States
Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Target Recruit Count
- 20
- Registration Number
- NCT00002174
- Locations
- ๐บ๐ธ
Ochsner Clinic, New Orleans, Louisiana, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath